Anxiety disorders in children and adolescents

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 19

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

IAPMHCONF04_036

تاریخ نمایه سازی: 8 شهریور 1404

چکیده مقاله:

Adolescence is a time of substantial change both physiologically and psychologically. It also is a period of time when individuals are particularly vulnerable to developing symptoms of anxiety disorders. This increased risk for the development of anxiety is likely due in part to the numerous transitions during this period. As a result, adolescence is a particularly important time regarding the development of psychopathology. This period often sets the stage for future beliefs about the self and others, developmental concerns, and interpersonal relationships, which all are factors that are important to the development of anxiety. Therefore, an accurate understanding of the vulnerability factors and the features of anxiety disorders is important for mental health professionals. Anxiety disorders are the most common psychiatric conditions in children and adolescents, affecting nearly ۱ in ۱۲ children and ۱ in ۴ adolescents. Anxiety disorders include specific phobias, social anxiety disorder, separation anxiety disorder, agoraphobia, panic disorder, and generalized anxiety disorder. Risk factors include parental history of anxiety disorders, socioeconomic stressors, exposure to violence, and trauma. The U.S. Preventive Services Task Force recommends screening for anxiety disorders in children eight years and older; there is insufficient evidence to support screening in children younger than eight years. Symptoms of anxiety disorders in children and adolescents are similar to those in adults and can include physical and behavioral symptoms such as diaphoresis, palpitations, and tantrums. Care should be taken to distinguish symptoms of a disorder from normal developmental fears and behaviors, such as separation anxiety in infants and toddlers. Several validated screening measures are useful for initial assessment and ongoing monitoring. Cognitive behavior therapy and selective serotonin reuptake inhibitors are the mainstay of treatment and may be used as monotherapies or in combination. Prognosis is improved with early intervention, caretaker support, and professional collaboration.

کلیدواژه ها:

نویسندگان

Hamaseh Naderi

MA degree in general psychology